FDA cleared edge OrthoPulse is FDA-cleared for use with both braces and clear aligners, signaling a strong regulatory position and a broad market opportunity for orthodontists adopting either traditional or aligner-based treatments.

Clinical outcomes focus Biolux emphasizes Light Accelerated technology to shorten treatment timelines. This presents a compelling value proposition to clinics seeking to differentiate offerings, improve patient throughput, and justify premium pricing or enhanced scheduling efficiency.

Strategic partnerships Recent collaborations with Ortho Arch in Canada and uLab Systems for AI-assisted planning expand distribution channels and integration into popular practice management and digital workflow ecosystems, enabling easier sales pitches and cross-sell opportunities.

Practice integration Summer Practice Integration Program aims to boost efficiency, outcomes, and profitability for orthodontists, creating a ready-to-market upsell opportunity for clinics to adopt OrthoPulse as part of a bundled treatment improvement plan.

Growth signals Revenue scale and external funding combined with a growing installed base across North America suggest a track record of market validation and potential for expanding sales through regional distributors, clinic networks, and integration partners.